FUMARIC ACID

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
114.0 -3.0 0 4 80.0 2 0.0
UNII
88XHZ13131
CAS
110-17-8
SYNONYMS
  • Fumaric Acid
  • Nsc-2752
  • Trans-Butenedioic Acid
  • Fema No. 2488
  • Fumaricum Acidum
  • Fumaricum Acidum [hpus]
  • Fumaric Acid [mart.]
  • Fumaric Acid [mi]
  • Fumaric Acid [fhfi]
  • Fumaric Acid [inci]
  • Fumaric Acid [fcc]
  • Fumarate
  • Fumaric Acid [ii]
  • Fumaric Acid [hsdb]
  • Fumaric Acid [usp-Rs]
  • Fumaric Acid [who-Dd]
  • Fumaric Acid [vandf]
  • Ethylenedicarboxylic Acid
  • (e)-Butenedioic Acid
  • Boletic-Acid
  • Allomaleic-Acid
  • 2(trans)-Butenedioic Acid
  • E-297
  • Ins-297
  • Ins No.297
ZINC ID(s)
Availability
Present in 82 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
INMT Indolethylamine N-methyltransferase Enzyme / Enzyme-Other

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT00002396 The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients Phase 1 Active, Not Recruiting
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects Phase 2 Withdrawn
NCT00002450 Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients Phase 3 Completed
NCT00002415 Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients Phase 2 Completed
NCT00007436 The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients Phase 3 Active, Not Recruiting
NCT00122512 Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV Phase 2 Terminated
NCT01634386 Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fasting Conditions Phase 1 Completed
NCT01634399 Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fed Conditions Phase 1 Completed
NCT01634373 Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Phase 1 Completed
NCT01815723 2015-06-01 Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis Phase 3 Not Yet Recruiting
NCT01528865 2015-04-01 Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma Phase 1/Phase 2 Not Yet Recruiting
NCT02351908 2015-02-01 Renal Integrase Study Phase 4 Not Yet Recruiting
NCT02337426 2015-02-01 Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Phase 1 Recruiting
NCT02343159 2015-02-01 Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients. Phase 4 Not Yet Recruiting
NCT02308319 2015-01-01 Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load Phase 4 Not Yet Recruiting
NCT02195518 2014-12-01 Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study Phase 4 Not Yet Recruiting
NCT02268396 2014-11-01 Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD Phase 3 Active, Not Recruiting
NCT02243735 2014-11-01 Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia Phase 4 Not Yet Recruiting
NCT02206555 2014-11-01 PrEP Demonstration Project (PRELUDE Study) Phase 4 Recruiting
NCT02271997 2014-10-01 Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass Phase 4 Enrolling By Invitation
NCT02224456 2014-10-01 Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis Phase 4 Not Yet Recruiting
NCT02196077 2014-08-01 Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Phase 2 Active, Not Recruiting
NCT02283853 2014-08-01 Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) Phase 3 Recruiting
NCT02228902 2014-08-01 Iron Absorption Trial Phase 4 Enrolling By Invitation
NCT02196714 2014-07-01 PK Study of PT003 and PT001 in Japanese Healthy Subjects Phase 1 Completed
NCT01853787 2014-07-01 Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study Phase 4 Recruiting
NCT02171208 2014-06-01 A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers Phase 1 Completed
NCT02062463 2014-06-01 Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Patients With Asthma Phase 4 Active, Not Recruiting
NCT02125604 2014-06-01 Gastrointestinal Tolerability Study Of Dimethyl Fumarate (DMF) In Participants With Relapsing-Remitting Multiple Sclerosis In Germany Phase 4 Recruiting
NCT02090413 2014-05-01 Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate (DMF)-Treated Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) Phase 4 Recruiting
NCT02090348 2014-05-01 Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With BG00012 or Standard of Care Phase 4 Not Yet Recruiting
NCT02148120 2014-04-01 A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler Phase 2 Completed
NCT02087631 2014-04-01 Safety and Tolerability of Quetiapine in Multiple Sclerosis Phase 1/Phase 2 Recruiting
NCT02128971 2014-04-01 A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo Phase 2 Recruiting
NCT02097849 2014-03-01 A Phase 3b Study of BG00012's Effect on Vaccination Response in Subjects With Relapsed Forms of Multiple Sclerosis Phase 3 Not Yet Recruiting
NCT01658891 2014-02-01 Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children Phase 3 Withdrawn
NCT01949467 2014-02-01 Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis. Phase 2 Recruiting
NCT02005588 2013-12-01 Treatment of Iron Deficiency Anemia With Pregnancy Phase 0 Recruiting
NCT01996124 2013-11-01 Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients Phase 4 Completed
NCT01975272 2013-11-01 The Use of Iron Therapy for Patients With Anemia After Surgery Phase 4 Not Yet Recruiting
NCT01953107 2013-11-01 Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. Phase 4 Recruiting
NCT01930708 2013-10-01 A Study Evaluating the Effectiveness of Tecfidera™ (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes Phase 4 Recruiting
NCT01709084 2013-10-01 A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment Phase 3 Active, Not Recruiting
NCT01908140 2013-09-01 Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Completed
NCT01940471 2013-09-01 Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B Phase 3 Active, Not Recruiting
NCT01924832 2013-08-01 BG00012 Regional Absorption Study Phase 1 Completed
NCT01915901 2013-08-01 PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily Phase 1 Completed
NCT01632891 2013-07-01 Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected Phase 1/Phase 2 Recruiting
NCT01858948 2013-07-01 SGA-induced Metabolic Syndrome in Bipolar Youth Phase 3 Recruiting
NCT01687218 2013-06-01 Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel Phase 2 Recruiting
NCT01838668 2013-03-01 An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) Phase 3 Recruiting
NCT01840605 2013-03-01 A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis Phase 3 Completed
NCT01777997 2013-02-01 FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir Phase 4 Active, Not Recruiting
NCT01745822 2013-01-01 Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand Phase 3 Recruiting
NCT01762995 2012-12-01 A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects Phase 1 Completed
NCT01656434 2012-11-01 Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448) Phase 3 Terminated
NCT01641367 2012-10-01 A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure Phase 4 Recruiting
NCT01491295 2012-09-01 Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients Phase 4 Recruiting
NCT01741623 2012-08-01 Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition Phase 1 Completed
NCT01744873 2012-08-01 Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition Phase 1 Completed
NCT01605890 2012-07-01 Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients Phase 2 Recruiting
NCT01605617 2012-06-01 Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate Phase 4 Terminated
NCT01641081 2012-06-01 Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma Phase 2 Completed
NCT01505114 2012-06-01 Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women Phase 2 Active, Not Recruiting
NCT01592305 2012-05-01 A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir Phase 1 Completed
NCT01566760 2012-05-01 A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers Phase 1 Completed
NCT01650441 2012-04-01 Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients Phase 2 Active, Not Recruiting
NCT01568112 2012-04-01 A Study in Healthy Volunteers to Evaluate Effects of Pre-Medication or Slow Dose Titration on Flushing and Gastrointestinal Events Phase 3 Completed
NCT01572792 2012-04-01 Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Completed
NCT01189318 2012-03-01 Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder Phase 2 Recruiting
NCT01712854 2012-03-01 Investigating the Effects of Symbicort on the Ventilatory Kinematics in Patients With Obstructive Disease With Optoelectronic Plethysmography Phase 4 Terminated
NCT01566149 2012-03-01 Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) Phase 3 Completed
NCT01671787 2012-03-01 A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B Phase 1 Completed
NCT01448616 2012-02-01 Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding Phase 4 Active, Not Recruiting
NCT01803087 2012-02-01 Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients Phase 2 Completed
NCT01522625 2012-01-01 Tenofovir in Chronic Hepatitis B With Mild ALT Elevation Phase 4 Recruiting
NCT01352715 2012-01-01 Study of Options for Second-Line Effective Combination Therapy (SELECT) Phase 3 Active, Not Recruiting
NCT01400412 2011-12-01 Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen Phase 2 Completed
NCT01515813 2011-11-01 Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation Phase 2 Withdrawn
NCT01462942 2011-10-01 Long-term Efficacy and Safety of Aclidinium/Formoterol Fixed-Dose Combination Phase 3 Completed
NCT01352117 2011-10-01 Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma Phase 3 Recruiting
NCT01437540 2011-09-01 Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 3 Completed
NCT01437397 2011-09-01 Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Completed
NCT01475032 2011-09-01 "Efficacy Study of the Product ""CHF 1535"" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children" Phase 3 Completed
NCT01450774 2011-09-01 Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children Phase 3 Completed
NCT01327651 2011-08-01 The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP) Phase 2 Completed
NCT01352988 2011-07-01 Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus Phase 2 Completed
NCT01349868 2011-05-01 PT005 MDI Dose Ranging Versus Foradil Aerolizer Study Phase 2 Completed
NCT01349803 2011-05-01 PT003 MDI Cardiovascular Safety Study Phase 2 Completed
NCT01321164 2011-04-01 Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis Phase 3 Completed
NCT01603173 2011-04-01 Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition Phase 1 Completed
NCT01326858 2011-04-01 Safety and Comfort of AL-4943A Ophthalmic Solution Phase 1 Completed
NCT01155375 2011-04-01 A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease Phase 3 Active, Not Recruiting
NCT01603186 2011-04-01 Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition Phase 1 Completed
NCT01066858 2011-03-01 Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and Breastfeeding Phase 4 Active, Not Recruiting
NCT01379508 2011-03-01 Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept Phase 4 Recruiting
NCT01300234 2011-03-01 Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) Phase 3 Active, Not Recruiting
NCT01234116 2011-02-01 Post-Exposure Prophylaxis in Health Care Workers Phase 4 Completed
NCT01281111 2011-02-01 Alternate Dosing Regimens of BG00012 in Healthy Volunteers Phase 1 Completed
NCT00799864 2011-01-01 A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents Phase 2 Active, Not Recruiting
NCT01285050 2011-01-01 Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds Phase 4 Recruiting
NCT01258803 2010-12-01 A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2) Phase 2 Completed
NCT01256177 2010-12-01 Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression Phase 3 Completed
NCT01254721 2010-12-01 A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study Phase 4 Terminated
NCT01213836 2010-11-01 Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia Phase 4 Completed
NCT01322451 2010-11-01 Oral Bioavailability of Two Solid Formulations of GLPG0259. Phase 1 Completed
NCT01165541 2010-09-01 A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency Phase 2 Completed
NCT01168310 2010-08-01 A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 2 Completed
NCT01587066 2010-08-01 Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression Phase 4 Withdrawn
NCT01043601 2010-07-01 Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control Phase 2 Withdrawn
NCT01566487 2010-06-01 Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition Phase 1 Completed
NCT01128114 2010-06-01 Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy Phase 4 Terminated
NCT01113593 2010-05-01 A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease Phase 2 Completed
NCT01088165 2010-05-01 The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis Phase 4 Recruiting
NCT01156311 2010-05-01 BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis Phase 2 Completed
NCT01085045 2010-03-01 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) Phase 2 Completed
NCT01049360 2009-12-01 Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo Phase 2 Completed
NCT01040091 2009-12-01 Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status Phase 1/Phase 2 Completed
NCT00929851 2009-10-01 BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate) Phase 3 Completed
NCT00995800 2009-10-01 Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma Phase 2 Completed
NCT00705679 2009-08-01 Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women Phase 2 Completed
NCT01033942 2009-08-01 Pre-Exposure Prophylaxis in YMSM Phase 2 Completed
NCT00896051 2009-08-01 TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients Phase 2 Completed
NCT00903084 2009-06-01 Examining Hair to Determine Tenofovir Exposure Phase 1 Not Yet Recruiting
NCT00931723 2009-06-01 Adult Bipolar Mania Phase 4 Completed
NCT00919607 2009-06-01 Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients Phase 1 Completed
NCT00811954 2009-05-01 Comparative Study of Three NNRTI-Sparing HAART Regimens Phase 3 Completed
NCT00882518 2009-04-01 Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients Phase 3 Completed
NCT00832650 2009-04-01 Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit Phase 1 Terminated
NCT00883493 2009-04-01 Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression Phase 3 Completed
NCT00852631 2009-02-01 Seroquel XR in Adults With Schizophrenia Phase 3 Terminated
NCT00828789 2009-02-01 VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer Phase 1 Completed
NCT00804622 2008-12-01 Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB) Phase 2 Completed
NCT00837343 2008-12-01 A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder Phase 4 Recruiting
NCT00774761 2008-11-01 A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease Phase 2 Completed
NCT00779506 2008-11-01 Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR) Phase 4 Completed
NCT00880490 2008-11-01 Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 1/Phase 2 Completed
NCT00734292 2008-09-01 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma Phase 2 Completed
NCT00734162 2008-09-01 Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection Phase 3 Active, Not Recruiting
NCT00746330 2008-08-01 Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma Phase 2 Completed
NCT00838032 2008-08-01 Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia Phase 4 Recruiting
NCT00736190 2008-08-01 A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection Phase 4 Completed
NCT00711009 2008-07-01 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) Phase 3 Completed
NCT00724711 2008-07-01 Safety and Efficacy Study of Switching From Epzicom to Truvada Phase 4 Completed
NCT00702676 2008-07-01 Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison Phase 1 Completed
NCT00592124 2008-06-01 Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women Phase 2 Completed
NCT00706914 2008-06-01 Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Phase 2 Completed
NCT00798434 2008-06-01 A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. Phase 4 Completed
NCT00647244 2008-06-01 Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients Phase 4 Completed
NCT00702325 2008-06-01 Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans Phase 4 Completed
NCT00660972 2008-05-01 Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF) Phase 1 Completed
NCT00557245 2008-05-01 Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples Phase 3 Completed
NCT00672490 2008-04-01 Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder Phase 4 Completed
NCT00633776 2008-03-01 Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT) Phase 4 Withdrawn
NCT00640601 2008-03-01 Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia Phase 3 Completed
NCT00658684 2008-02-01 Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder. Phase 3 Completed
NCT00622245 2008-01-01 Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression Phase 2 Terminated
NCT00498628 2007-12-01 Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency Phase 2 Completed
NCT00551018 2007-12-01 Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875) Phase 2 Completed
NCT00561951 2007-11-01 Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder. Phase 2 Completed
NCT01074645 2007-11-01 Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure Phase 4 Completed
NCT00534599 2007-08-01 Generalized Anxiety Disorder Adjunct Study Phase 3 Completed
NCT00458393 2007-06-01 Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men Phase 3 Active, Not Recruiting
NCT00442962 2007-05-01 HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV Phase 4 Completed
NCT01078818 2007-05-01 Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation Phase 4 Completed
NCT00102206 2007-05-01 A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy Phase 2 Completed
NCT00476073 2007-04-01 Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma Phase 3 Completed
NCT00444925 2007-04-01 Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB) Phase 3 Completed
NCT00370500 2007-04-01 Quetiapine and the Dopaminergic Epigenetic Control Phase 4 Completed
NCT00675896 2007-04-01 A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome Phase 4 Completed
NCT00475813 2007-03-01 Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma Phase 3 Completed
NCT00507234 2007-03-01 Study in Subjects Greater Than 40 Years of Age With COPD Phase 3 Completed
NCT00448669 2007-03-01 Botswana TDF/FTC Oral HIV Prophylaxis Trial Phase 2/Phase 3 Completed
NCT00953134 2007-02-01 Periconceptional Iron Supplementation in Rural Bangladesh Phase 0 Completed
NCT00426023 2007-02-01 Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis Phase 3 Completed
NCT00569712 2007-01-01 Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol Phase 1 Completed
NCT00422123 2007-01-01 Phase 3 /Seroquel SR Acute Mania Monotherapy - US Phase 3 Completed
NCT00425100 2007-01-01 A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients Phase 3 Completed
NCT00428350 2006-12-01 Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic Phase 4 Completed
NCT00422214 2006-12-01 Phase III/Seroquel SR Bipolar Depression Monotherapy - US Phase 3 Completed
NCT00120471 2006-11-01 Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies Phase 1 Completed
NCT00403286 2006-11-01 A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease Phase 2 Completed
NCT00089505 2006-11-01 NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission Phase 3 Completed
NCT00418509 2006-11-01 Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers Phase 1 Completed
NCT00383240 2006-09-01 Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED) Phase 3 Completed
NCT00383552 2006-09-01 Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED) Phase 3 Completed
NCT00648817 2006-07-01 Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers Phase 4 Completed
NCT00393991 2006-07-01 Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma Phase 3 Completed
NCT00393952 2006-06-01 New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma Phase 3 Completed
NCT00394199 2006-06-01 Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma Phase 3 Completed
NCT00322595 2006-05-01 Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder Phase 3 Completed
NCT00326105 2006-04-01 Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders Phase 3 Completed
NCT00329264 2006-04-01 Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder Phase 3 Completed
NCT00320268 2006-04-01 Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder Phase 3 Completed
NCT00308191 2006-04-01 A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD Phase 3 Completed
NCT00215449 2006-04-01 Study in Patients With COPD Phase 3 Completed
NCT00545558 2006-04-01 Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV Phase 1 Completed
NCT00298363 2006-04-01 Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. Phase 2 Completed
NCT00326144 2006-04-01 Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders Phase 3 Completed
NCT00329446 2006-04-01 Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder Phase 3 Completed
NCT00321490 2006-04-01 Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder Phase 3 Completed
NCT00099632 2006-03-01 Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy Phase 2 Completed
NCT00394121 2006-03-01 New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma Phase 3 Completed
NCT00050895 2006-03-01 Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients Phase 3 Completed
NCT00733668 2006-03-01 Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder Phase 2 Completed
NCT00260078 2006-02-01 Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children Phase 1/Phase 2 Completed
NCT00280371 2006-01-01 A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD Phase 3 Completed
NCT00114686 2006-01-01 Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder Phase 3 Completed
NCT00280358 2005-12-01 A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator. Phase 1 Completed
NCT00278941 2005-12-01 Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder Phase 3 Completed
NCT00215397 2005-12-01 Study in Patients With Asthma Phase 2 Completed
NCT00215410 2005-10-01 Study in Patients With Asthma Phase 2 Completed
NCT00215384 2005-10-01 Study in Patients With COPD Phase 2 Completed
NCT00255515 2005-09-01 Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia Phase 4 Completed
NCT00139932 2005-09-01 Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) (COMPLETED) Phase 4 Completed
NCT00215423 2005-09-01 Study in Patients With COPD Phase 2 Completed
NCT00118898 2005-09-01 Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults Phase 3 Completed
NCT00111150 2005-09-01 Botswana Tenofovir Oral HIV Prophylaxis Trial Phase 2/Phase 3 Terminated
NCT00356616 2005-09-01 Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients Phase 4 Terminated
NCT00206141 2005-08-01 Seroquel in Bipolar Depression Versus Lithium Phase 3 Completed
NCT00448578 2005-08-01 Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients Phase 3 Completed
NCT00139074 2005-07-01 Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients Phase 4 Terminated
NCT00254787 2005-06-01 Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients Phase 2 Completed
NCT00027339 2005-06-01 Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV Phase 2 Completed
NCT00116805 2005-06-01 A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B Phase 3 Active, Not Recruiting
NCT00122070 2005-05-01 Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder Phase 3 Completed
NCT00033163 2005-05-01 A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV Phase 2 Completed
NCT00084136 2005-05-01 Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings Phase 4 Completed
NCT00119652 2005-05-01 Seroquel in Bipolar Depression Versus SSRI Phase 3 Completed
NCT00119379 2005-04-01 Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults Phase 2 Completed
NCT00105079 2005-04-01 GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Phase 3 Completed
NCT00136266 2005-03-01 Adherence With Iron Sprinkles Among High-Risk Infants Phase 3 Completed
NCT00314184 2005-03-01 Quetiapine Fumarate Bipolar Maintenance Monotherapy Phase 3 Completed
NCT00215436 2005-03-01 A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD Phase 3 Completed
NCT00074581 2005-02-01 Preventing Sexual Transmission of HIV With Anti-HIV Drugs Phase 3 Active, Not Recruiting
NCT00131677 2005-02-01 Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men Phase 2 Completed
NCT00090779 2005-01-01 Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV Phase 2 Terminated
NCT00306540 2004-12-01 Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder Phase 3 Completed
NCT00394368 2004-11-01 EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI Phase 3 Completed
NCT00830102 2004-10-01 Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients Phase 2 Completed
NCT00413387 2004-09-01 Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®) Phase 3 Completed
NCT00090324 2004-09-01 Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia Phase 3 Completed
NCT00227305 2004-08-01 Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder Phase 3 Completed
NCT00304473 2004-08-01 Fast Titration in the Treatment of Schizophrenia, Taiwan Phase 3 Completed
NCT00090311 2004-07-01 Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania Phase 3 Completed
NCT00122486 2004-07-01 Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV Phase 2 Completed
NCT00083954 2004-06-01 Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression Phase 3 Completed
NCT00085891 2004-06-01 Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia Phase 3 Completed
NCT00254748 2004-06-01 Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients Phase 2 Completed
NCT00107731 2004-04-01 Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder Phase 3 Completed
NCT00081380 2004-03-01 Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder Phase 3 Completed
NCT00076791 2004-03-01 Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants Phase 1 Completed
NCT00229645 2003-11-01 A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI’s, and SNRI’s Treatment in Major Depression With Anxiety Phase 4 Completed
NCT00867867 2003-10-01 Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries Phase 1 Completed
NCT00206102 2003-09-01 A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder Phase 4 Completed
NCT00112047 2003-07-01 Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects Phase 3 Completed
NCT00449397 2003-07-01 Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis Phase 3 Completed
NCT00046033 2003-03-01 Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance Phase 2 Completed
NCT00055120 2003-03-01 When to Start Anti-HIV Drugs in Patients With Opportunistic Infections Phase 4 Completed
NCT00270556 2003-01-01 Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART. Phase 2 Completed
NCT00621647 2002-09-01 Seroquel- Agitation Associated With Dementia Phase 3 Completed
NCT00060489 2002-09-01 Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression Phase 3 Completed
NCT00215358 2002-07-01 Study in Patients With Asthma Phase 2 Completed
NCT00215371 2002-07-01 Study in Patients With Asthma Phase 2 Completed
NCT02251145 2002-05-01 Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers Phase 1 Completed
NCT00254735 2002-04-01 Quetiapine Augmentation in Severe Obsessive Compulsive Disorder Phase 3 Completed
NCT00254774 2002-01-01 Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling Phase 3 Completed
NCT00305422 2001-11-01 Effect of Quetiapine on Negative Symptoms and Cognition Phase 3 Completed
NCT00034905 2001-07-01 A Comparison of Seroquel vs. Risperidone in Schizophrenia Phase 4 Completed
NCT02182557 2001-06-01 WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients Phase 3 Completed
NCT02182544 2001-06-01 WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis Phase 3 Completed
NCT00158821 2000-03-01 Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. Phase 3 Completed
NCT00004886 1999-12-01 MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors Phase 1 Completed
NCT00000296 1997-11-01 Role of Metabolites in Nicotine Dependence (4) - 13 Phase 2 Completed
NCT00000288 1995-12-01 Role of Metabolites in Nicotine Dependence (2) - 5 Phase 2 Completed
NCT00000284 1995-02-01 Role of Metabolites in Nicotine Dependence (1) - 1 Phase 2 Completed
NCT00913549 1989-12-01 To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets Phase 1 Completed

(Browse) Purchasable Analogs in ZINC

Functions of Fumaric Acid

Ds - Dietary supplement

Dosages

Route Formulation Per Unit Dose
Oral Capsule, Sustained Action 150MG
Oral Powder, For Oral Solution 200MG
Oral Suspension 0.5%
Oral Syrup 0.02%
Oral Tablet 80MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 10MG
Oral Tablet, Controlled Release 36.5MG
Oral Tablet, Extended Release 15MG
Oral Tablet, Sustained Action 55.56MG

More Information

Usage Over Time

Comments